Almost all of the medical prescriptions were for pure CBD oil.

Through July 19, exactly 300 prescriptions had been approved for a cannabidiol (CBD) oral solution and the only other approval was for Sativex, which has both THC and CBD as active ingredients, the Ministry of Food and Drug Safety (MFDS) told Marijuana Business Daily.

South Korean medical cannabinoid imports surpass 300 units since law passed